Rybelsus 7mg Tablet belongs to the GLP-1 (glucagon-like peptide) group of diabetes medicines
The participants also saw 1.6 percent average drop in A1C levels, a measurement that estimates average blood sugar levels over the previous two to three months
Common stomach effects In pooled STEP 1-3 data on the 2.4 mg dose, nausea occurred in 43.9% of participants (vs 16.1% on placebo), diarrhea in 29.7% (vs 15.9%), vomiting in 24.5% (vs 6.3%), and constipation in 24.2% (vs 11.1%)
So, even though emerging evidence looks promising, we still need to go a long way to establish these drugs as safe and effective treatment options for type 1 diabetic patients
Other medicines that slow the gut
Okay, can we just talk about how amazing this program is